American Society of Clinical Oncology (ASCO)
JCO Oncology Practice
,  том 21 ,  издание 2 ,  страницы 120-122

Beginning at the End? Rethinking the Timing of Enrollment Into Early Phase Clinical Trials

Тип публикации: Journal Article
Дата публикации: 2025-02-01
American Society of Clinical Oncology (ASCO)
scimago Q1
wos Q1
БС3
SJR: 2.346
CiteScore: 7.5
Impact factor: 4.6
ISSN: 26881527, 26881535
Найдено 

Вы ученый?

Создайте профиль, чтобы получать персональные рекомендации коллег, конференций и новых статей.
Метрики
0
Поделиться
Цитировать
ГОСТ |
Цитировать
ГОСТ Скопировать
Mahadevan A., Azizi A., Imagawa D. K. Beginning at the End? Rethinking the Timing of Enrollment Into Early Phase Clinical Trials // JCO Oncology Practice. 2025. Vol. 21. No. 2. pp. 120-122.
ГОСТ со всеми авторами (до 50) Скопировать
Mahadevan A., Azizi A., Imagawa D. K. Beginning at the End? Rethinking the Timing of Enrollment Into Early Phase Clinical Trials // JCO Oncology Practice. 2025. Vol. 21. No. 2. pp. 120-122.
RIS |
Цитировать
RIS Скопировать
TY - JOUR
DO - 10.1200/op-24-00488
UR - https://ascopubs.org/doi/10.1200/OP-24-00488
TI - Beginning at the End? Rethinking the Timing of Enrollment Into Early Phase Clinical Trials
T2 - JCO Oncology Practice
AU - Mahadevan, Aditya
AU - Azizi, Armon
AU - Imagawa, David K
PY - 2025
DA - 2025/02/01
PB - American Society of Clinical Oncology (ASCO)
SP - 120-122
IS - 2
VL - 21
PMID - 39079064
SN - 2688-1527
SN - 2688-1535
ER -
BibTex |
Цитировать
BibTex (до 50 авторов) Скопировать
@article{2025_Mahadevan,
author = {Aditya Mahadevan and Armon Azizi and David K Imagawa},
title = {Beginning at the End? Rethinking the Timing of Enrollment Into Early Phase Clinical Trials},
journal = {JCO Oncology Practice},
year = {2025},
volume = {21},
publisher = {American Society of Clinical Oncology (ASCO)},
month = {feb},
url = {https://ascopubs.org/doi/10.1200/OP-24-00488},
number = {2},
pages = {120--122},
doi = {10.1200/op-24-00488}
}
MLA
Цитировать
MLA Скопировать
Mahadevan, Aditya, et al. “Beginning at the End? Rethinking the Timing of Enrollment Into Early Phase Clinical Trials.” JCO Oncology Practice, vol. 21, no. 2, Feb. 2025, pp. 120-122. https://ascopubs.org/doi/10.1200/OP-24-00488.